Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Imbalanced Angiogenesis in Peripartum Cardiomyopathy ― Diagnostic Value of Placenta Growth Factor ―

1 Jan 2017

Abstract excerpt

BACKGROUND: Concentrations of the anti-angiogenic factor soluble fms-like tyrosine kinase-1 (sFlt-1) are altered in peripartum cardiomyopathy (PPCM). In this study we investigated changes in the angiogenesis balance in PPCM. METHODS AND RESULTS: Plasma concentrations of sFlt-1 and the pro-angiogenic placenta growth factor (PlGF) were determined in patients with PPCM during the post-partum phase (n=83), in healthy...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiovascular Issues in Pregnancy
Share to Pregnancy and preeclampsia studies
Share to Pregnancy-related medical research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28552862
DOI: 10.1253/circj.cj-16-1193

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Imbalanced Angiogenesis in Peripartum Cardiomyopathy ― Diagnostic Value of Placenta Growth Factor ―PMID 28552862Read ↗

Peripartum cardiomyopathy: basic mechanisms and hope for new therapiesSemantic proximity Read ↗

Angiogenic growth factors in the diagnosis and prediction of pre-eclampsiaSemantic proximity Read ↗

A Review of the Diagnosis, Risk Factors, and Role of Angiogenetic Factors in Hypertensive Disorders of PregnancySemantic proximity Read ↗

Connecting the Dots: Exploring the Interplay Between Preeclampsia and Peripartum Cardiomyopathy.Semantic proximity Read ↗

Role of angiogenic factors in the pathogenesis and management of pre‐eclampsiaSemantic proximity Read ↗

Prognostic value of angiogenic markers in pregnancy with fetal growth restrictionSemantic proximity Read ↗

Peripartum Cardiomyopathy From a Genetic Perspective.Semantic proximity Read ↗

Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy.Semantic proximity Read ↗

Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disordersSemantic proximity Read ↗

Characterisation of Cardiac Health in the Reduced Uterine Perfusion Pressure Model and a 3D Cardiac Spheroid Model, of PreeclampsiaSemantic proximity Read ↗

Hypertensive disorders of pregnancy and peripartum cardiomyopathy: A nationwide cohort studySemantic proximity Read ↗

Cardiomyopathy Prevalence and Pregnancy-Related MortalitySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.